CONMED Corp — Director's Dealing 2014

Oct 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-10-29

Reporting Person: SHALLISH ROBERT D JR (EVP, Finance, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-29	Common Stock	M	10410	$31.40	Acquired	64325	Direct
2014-10-29	Common Stock	S	10410	$41.6696	Disposed	53915	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-29	Options To Purchase Common Stock	$31.40	M	10410	Disposed	2015-05-17	Common Stock (10410)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.45 to $42.05. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: 5 year vesting schedule, 20% vesting each year starting 5/17/2006.